- Issuer ticker
-
N/A
- Reported as of
-
18 May 2023
- Net transaction value
-
-$4,739
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
22 May 2023, 21:18:55 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Christopher Klein
Filing notes and source
Key filing fact
Christopher Klein filed Form 4 for RVL Pharmaceuticals plc on 22 May 2023.
Key facts
- This page summarizes Christopher Klein's Form 4 filing for RVL Pharmaceuticals plc.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 May 2023, 21:18.
Change
- Previous filing in this sequence was filed on 26 Jan 2023.
- Current net transaction value: -$4,739.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVLP
transaction
Ordinary Shares
Tax liability
- Transaction value
- -$4,739
- Shares
- -5,447
- Change %
- -2.9%
- Price
-
$0.8700
- Shares after
- 180,573
- Date
- 18 May 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.